PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 1, 2003Clinical Chemistry271 citationsOpen Access

Evaluation of Human Serum Albumin Cobalt Binding Assay for the Assessment of Myocardial Ischemia and Myocardial Infarction

View Full Paper
NBNadhipuram V. BhagavanELErnest M LaiPRPatricia Ríos

Key Result

The Co(II)-albumin binding assay accurately detected myocardial ischemia with an area under the ROC curve of 0.95 (95% CI, 0.92-0.99), yielding 88% sensitivity and 94% specificity at a 0.50 ABSU cutoff.

Study Design

Type

Observational (n=167)

Blinding

Double-blind

Multicenter

No

Structured PICO

Does the Co(II)-albumin binding assay accurately detect myocardial ischemia in emergency department patients?

P
Population
167 patients treated at an emergency department evaluated for myocardial ischemia to assess the diagnostic accuracy of a Co(II)-albumin binding assay.
E
Exposure
Co(II)-albumin binding assay
C
Comparator
Standard coronary disease indicators (creatine kinase, CK-MB, cardiac troponin I, and electrocardiographic findings)
O
Outcome
Detection of myocardial ischemia (sensitivity, specificity, and area under the ROC curve)surrogate

The Co(II)-albumin binding assay is highly sensitive and specific for detecting myocardial ischemia but performs poorly in distinguishing between ischemia with and without myocardial infarction.

Main Result

Effect estimate: AUC 0.95 (95% CI 0.92-0.99)

p-value: p=<0.0001

Limitations

  • The Co(II)-albumin binding assay was a poor discriminator between ischemic individuals with and without myocardial infarction (AUC 0.66).

Abstract

BACKGROUND: Clinical diagnoses were correlated with results of a Co(II)-albumin binding assay in 167 patients treated at an emergency department of a health maintenance organization. METHODS: Patients were evaluated as being nonischemic or potentially ischemic through standard coronary disease indicators creatine kinase (CK), CK-MB, cardiac troponin I, and electrocardiographic findings and were tested by a Co(II)-albumin binding assay. Samples were tested anonymously, and the study was double-blinded. The sensitivity and specificity of this assay for the detection of ischemia were evaluated by ROC curve analysis. Known Co(II) binding sites on albumin were analyzed by N-terminal amino acid sequencing. RESULTS: The mean absorbance units (ABSU) +/- 2 SD for non-myocardial ischemic and myocardial ischemic individuals measured at 470 nm were 0.43 +/- 0.10 and 0.63 +/- 0.25, respectively (P or =0.70) individuals and one nonischemic individual tested. However, only one individual with a high ABSU (0.80) had two missing amino acid residues (DA) from the N-terminal region. Clinical diagnosis for this patient did not reveal an ischemic event. CONCLUSIONS: The Co(II)-albumin binding test may serve as a useful diagnostic tool in emergency facilities for the assessment of myocardial ischemia. High and low ABSU were associated with myocardial ischemic individuals and non-myocardial ischemic individuals, respectively. However, the Co(II)-albumin binding was a poor discriminator between ischemic individuals with and without MI.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bhagavan et al. (2003) conducted an observational in Myocardial ischemia (n=167). Co(II)-albumin binding assay vs. Standard coronary disease indicators (nonischemic vs potentially ischemic) was evaluated on Detection of myocardial ischemia (AUC 0.95, 95% CI 0.92-0.99, p=<0.0001). The Co(II)-albumin binding assay accurately detected myocardial ischemia with an area under the ROC curve of 0.95 (95% CI, 0.92-0.99), yielding 88% sensitivity and 94% specificity at a 0.50 ABSU cutoff.

synapsesocial.com/papers/6a49a087bf54f04e123b46aehttps://doi.org/10.1373/49.4.581
Ask AI
Helpful
Bookmark
Share
View Full Paper